Faraz Ali
CEO,
Tenaya Therapeutics
Robert Ang
President & CEO,
Vor Biopharma
Catherine Bollard
Director of the Center for Cancer and Immunology Research,
Children's National Hospital and The George Washington University
Moya Daniels
Chief Quality Officer,,
Savanna Biotherapeutics
Lisa Deschamps
CEO & Executive Board Member,
AviadoBio
Debbie Drane
SVP, Strategic Projects,
CSL Behring
Matthew Durdy
Chief Executive,
CGT Catapult
George Eastwood
Board Chair & Executive Director,
Emily Whitehead Foundation
Anne-Virginie Eggimann
Chief Regulatory Officer,
Tessera Therapeutics
Miguel Forte
CEO,
Kiji Therapeutics
Audrey Greenberg
Founder,
Center for Breakthrough Medicines
Sadik Kassim
CTO & CSO,
Danaher Genomic Medicines
Brett Kopelan
Executive Director,
Debra of America
Ann Lee
Chief Technology Officer,
Prime Medicine
Anshul Mangal
President,
Project Farma/Precision ADVANCE
Adora Ndu
Chief Regulatory Officer & EVP Portfolio Strategy and Management,
bridgebio
Susan Nichols
CEO,
Propel Biosciences
Karah Parschauer
Chief Legal Officer & EVP,
Ultragenyx
Kinnari Patel
President, Head of R&D & COO,
Rocket Pharma
Jacob Petersen
SVP, Head of Global Nucleic Acid Therapies,
A Novo Nordisk Company
Louise Rodino-Klapac
Executive Vice President, Chief Scientific Officer,
Sarepta Therapeutics
Alberto Santagostino
Former SVP, Head of Cell & Gene Technologies Business Unit,
Lonza
Laura Sepp-Lorenzino
EVP & Chief Scientific Officer,
Intellia Therapeutics
Christy Siegel
SVP & US Therapeutic Area Head, Immunology,
Novartis
Manny Simons
CEO & Co-Founder; SVP, Gene Therapy,
Akouos; Eli Lilly
Bob Smith
Venture Partner,
OrbiMed
Devyn Smith
CEO,
Arbor Biotechnologies
Fyodor Urnov
Director, Technology & Translation,
Innovative Genomics Institute
Christopher Vann
SVP, COO,
Autolus Therapeutics
Kristin Yarema
President & CEO,
Poseida Therapeutics
Richard Wilson
SVP, Primary Focus Lead – Genetic Regulation,
Astellas
Ran Zheng
CEO,
Landmark Bio
